Deputy Chief Executive Officer

Tanya Zharov

With over 20 years of international experience in biotechnology, healthcare and financial services as an executive and corporate lawyer, Tanya Zharov brings with her a strong track record in business and innovation-driven global life science to Alvotech. She guides Icelandic operations and global administration, with her responsibility extending across HR, business operations, services and facilities. She also works in partnership with the CEO, Mark Levick, and members of the corporate leadership team to instill a strong sense of culture across all global locations.

Prior to joining Alvotech, she was the deputy CEO and Compliance Officer at deCODE genetics, a renowned Icelandic world leader in human genetics acquired by Amgen in 2012. A lawyer by training, she also acted as Corporate Counsel, leading the securities regulation and compliance team behind deCODE’s US IPO, the first of its kind for an Icelandic company.

In-between her stints at deCODE, Tanya was a Founding Partner and Deputy CEO of Audur Capital, an Icelandic securities firm, where her responsibilities spanned legal affairs, wealth management, corporate finance, private equity and capital markets. She is a specialist in US and global public markets law, regulation and best practices. Early in her career, Tanya served as a Tax Partner at PricewaterhouseCoopers and she holds a Cand. Juris law degree from the University of Iceland. Tanya is a European Patent Attorney.